View Clinical Trial (Medical Research Study)
Evaluating Intervention Responsiveness in People With Multiple Sclerosis
| City: |
|
Baltimore |
| State: |
|
Maryland |
| Zip Code: |
|
21205 |
| Conditions: |
|
Multiple Sclerosis |
| Purpose: |
|
The purpose is to see how multiple sclerosis (MS) is associated with strength and sensation
using MRI, in persons with MS. The investigators will also see whether exercise can improve
these symptoms for persons with MS.
|
| Study Summary: |
|
Multiple sclerosis (MS) is a chronic inflammatory disorder that damages myelin sheaths and
axons in the brain and spinal cord. Within ten years of being diagnosed with MS, a majority
of people will experience disability, most often walking impairments. The currently
available pharmacologic treatments offer protection from new attacks but do not help with
recovery; thus, in many cases the only hope for improvement, is through physical
rehabilitation.
Rehabilitative interventions, such as progressive resistance training (PRT), have been shown
to improve strength and sometimes walking in many individuals with MS. However, there are
also many individuals who do not respond, which tends to be ignored in the literature. In
addition, most intervention studies measure the primary impairment (e.g, strength) with
little or no consideration for other impairments (e.g., sensory loss) and any effects on
more complicated movements (e.g. standing, or changing direction). Since MS is so
heterogeneous, it would be helpful to know which individuals are likely to benefit from
rehabilitation.
Standard MS care uses MRI for diagnosis, identification of inflammatory lesions, and
determination of treatment efficacy. Conventional rehabilitation relies on clinical
judgment, rating scales and impairment measures to determine treatment efficacy. The
investigators would like to understand how behavioral impairments and MRI findings relate to
each other, and predict rehabilitation potential for people with MS. The investigators have
previously shown that damage measured using tract specific MRI, specifically magnetization
transfer (MTI) and diffusion tensor imaging (DTI), correlates with physical impairments in
individuals with MS. Here the investigators propose to determine whether measures of
clinical impairment and tract specific MRI can improve our ability to predict who will
respond best to a PRT exercise intervention by improving functional movement. The
investigators will perform a PRT intervention. The investigators will measure sensory and
motor impairments and walking ability before and after the intervention. MRI will be done
before treatment to assess the integrity of critical motor (corticospinal, CST) and sensory
(dorsal column-medial lemniscus, DC-ML) tracts across the cervical spinal cord and brain.
The investigators hypothesize that a combination of impairment measures and MRI measure will
predict improvement in functional movement following three months of PRT.
|
| Criteria: |
|
Inclusion Criteria:
- Confirmed diagnosis of MS
- If on immunomodulatory therapy, subjects have to have been on that therapy for at
least 6 months prior to the start of the study.
- Medically stable
- Able to follow complex directions as determined by a score of less than or equal to 1
on a subset of questions taken from the NIH Stroke scale
- Normal passive range of motion at the hips, knees, and ankles with minimum to no pain
- Scale of 3 to 5.5 on the Expanded Disability Status Scale, pyramidal Functional
Composite Score of greater than or equal to 2
Exclusion Criteria:
- Evidence of other neurological deficit that could interfere, such as previous stroke
or muscle disease
- Congestive heart failure
- MS exacerbation within 8 weeks of study start
- MS exacerbation affecting CST or DC-ML tracts
- peripheral artery disease with claudication
- cancer
- pulmonary or renal failure
- unstable angina
- uncontrolled hypertension (greater than 190/110 mmHg)
- orthopedic or pain conditions
- history of kidney disease, due to potential of gadolinium reactions leading to
nephrogenic systemic fibrosis (NSF)
- because pregnancy may change the MRI signals that we are studying, we have chosen not
to enroll pregnant women in this study
Healthy controls have the same age and exclusion criteria as people with multiple
sclerosis except that they must have normal neurological function
|
| NCT ID: |
|
NCT01632293 |
| Primary Contact: |
|
Principal Investigator
Kathleen M Zackowski, Ph.D.
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Rhul Marasigan, BS
Phone: 443-923-2716
Email: marasigan@kennedykrieger.org
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Baltimore, Maryland 21205
United States
There is no listed contact information for this specific location.
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 23, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|